Columbia Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,795
Closed -$318K 165
2020
Q1
$318K Sell
1,795
-845
-32% -$159K 0.08% 119
2019
Q4
$5.05K Sell
2,640
-870
-25% -$157K 0.12% 120
2019
Q3
$591K Sell
3,510
-2,720
-44% -$443K 0.15% 104
2019
Q2
$1.04M Sell
6,230
-120
-2% -$16.6K 0.27% 77
2019
Q1
$930K Sell
6,350
-500
-7% -$72.5K 0.25% 78
2018
Q4
$916K Sell
6,850
-5,331
-44% -$874K 0.28% 73
2018
Q3
$2.32M Buy
12,181
+2,234
+22% +$410K 0.61% 45
2018
Q2
$1.66M Sell
9,947
-280
-3% -$45K 0.48% 54
2018
Q1
$1.72M Buy
10,227
+3,933
+62% +$660K 0.5% 54
2017
Q4
$1.03M Sell
6,294
-1,660
-21% -$298K 0.3% 78
2017
Q3
$1.63M Buy
7,954
+101
+1% +$23.5K 0.5% 52
2017
Q2
$1.91M Buy
7,853
+1,495
+24% +$351K 0.62% 51
2017
Q1
$1.52M Buy
+6,358
New +$1.48M 0.51% 54

Other funds holding AGN

Columbia Asset Management's AGN Position: Q2 2020 in Review

Columbia Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,795 shares — an estimated $318K sold.

Columbia Asset Management first reported a position in AGN in Q1 2017 and held it in 13 quarters. The position peaked at $2.32M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Columbia Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Columbia Asset Management sold 1,795 Allergan plc shares in Q2 2020, an estimated $318K.
  • Columbia Asset Management first reported a position in Allergan plc in Q1 2017 and held it in 13 quarters.
  • Columbia Asset Management's Allergan plc position peaked at $2.32M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Columbia Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.